Vitamin C linked to fewer deaths in blood disorder trial

Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications.

An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo.

Dans Santé, FlexChar place cette histoire au centre de la journée : Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. FlexChar la retient parce qu’elle concentre recherches et discussion.